Press release
Insomnia Market Outlook 2031: From US$ 3.8 Billion in 2022 to US$ 6.4 Billion by 2031, Driven by Rising Prevalence and Innovative Therapies
The global insomnia market, valued at US$ 3.8 billion in 2022, is projected to reach US$ 6.4 billion by 2031, growing at a compound annual growth rate (CAGR) of 6.0% from 2023 to 2031. Insomnia therapeutics include prescription medications (e.g., benzodiazepines, non-benzodiazepines), over-the-counter (OTC) sleep aids, cognitive behavioral therapy (CBT-I), and emerging digital therapeutics. This article explores the market dynamics, key drivers, challenges, and opportunities shaping the insomnia market through 2031, highlighting its role in addressing a growing global sleep disorder burden.Get Sample PDF Brochure from here: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=20246
Market Overview
The insomnia market encompasses treatments for sleep disorders characterized by difficulty falling or staying asleep, affecting millions globally. Valued at US$ 3.8 billion in 2022, the market is expected to grow at a CAGR of 6.0% from 2023 to 2031, reaching US$ 6.4 billion by 2031. Growth is driven by increasing insomnia prevalence, advancements in pharmacological and non-pharmacological therapies, and rising awareness, particularly in North America, Europe, and Asia-Pacific.
Key Drivers of Growth
Rising Prevalence of Insomnia
Insomnia is increasingly common due to stress, lifestyle changes, and comorbidities like anxiety and depression, affecting urban populations in the U.S., Europe, and China. This drives demand for both prescription and OTC treatments.
Advancements in Treatment Options
Newer medications, such as orexin receptor antagonists (e.g., suvorexant) and dual orexin receptor antagonists (DORAs), offer improved safety profiles over traditional benzodiazepines, boosting adoption in North America and Europe.
Growth in Digital Therapeutics
Digital platforms offering CBT-I, sleep tracking, and personalized interventions are gaining traction, particularly in tech-savvy markets like the U.S. and Japan, with a projected market value of US$ 5.16 billion by 2031 for digital insomnia therapeutics alone.
Increasing Awareness and Diagnosis
Public health campaigns and improved diagnostic tools are reducing stigma and increasing treatment-seeking behavior, particularly in Asia-Pacific and Europe, where sleep health awareness is rising.
Top Companies:
Paratek Pharmaceuticals, Inc.
Sumitomo Dainippon Pharma Co., Ltd.
Teva Pharmaceutical Industries Limited
Vanda Pharmaceuticals Inc.
Takeda Pharmaceutical Company Limited
Pfizer Inc.
Sanofi S.A
Merck & Co., Inc.
Viatris Inc.
Visit our report to discover essential insights and analysis - https://www.transparencymarketresearch.com/insomnia-market.html
Challenges and Barriers
High Costs of Advanced Therapies
Novel medications and digital therapeutics are expensive, limiting access in developing regions like Africa and parts of Asia-Pacific, where affordability remains a barrier.
Side Effects of Pharmacological Treatments
Traditional drugs like benzodiazepines, which dominated the U.S. market in 2024, are associated with dependency and cognitive side effects, reducing patient compliance globally.
Regulatory and Reimbursement Challenges
Stringent FDA and EMA regulations for new insomnia drugs and limited insurance coverage for digital therapeutics slow market entry, particularly in emerging markets like India and Brazil.
Market Valuation Discrepancies
Significant variability in reported market sizes (e.g., US$ 5.44 billion in 2024 per vs. US$ 3.8 billion in 2022 per) suggests differences in scope (e.g., including sleep aids or broader sleep disorders), complicating forecasting.
Regional Insights
North America leads the insomnia market, driven by the U.S., due to high prevalence, advanced healthcare infrastructure, and adoption of novel therapies, though with a lower CAGR of 3.8% from 2025-2030. Europe, particularly Germany and the UK, follows, supported by robust reimbursement and growing CBT-I adoption. Asia-Pacific, led by China and Japan, is a fast-growing region due to rising stress-related insomnia and healthcare investments. Emerging markets in Latin America and Africa show potential but face cost and awareness barriers.
Future Opportunities
Digital and Non-Pharmacological Therapies: Expanding CBT-I platforms and wearable sleep tech could address unmet needs, particularly in North America and Asia-Pacific.
Emerging Market Growth: Improving healthcare access in India and Brazil could unlock demand for affordable OTC and generic treatments.
Personalized Medicine: Biomarkers and genetic profiling for tailored insomnia treatments could gain traction in the U.S. and Europe.
Public-Private Partnerships: Collaborations to promote sleep health awareness could drive demand in Asia-Pacific and Latin America.
Browse More Trending Research Reports:
Caustic Soda Market: https://www.einnews.com/pr_news/770374745/caustic-soda-industry-trends-market-valuation-to-reach-usd-59-3-billion-by-2031-growing-at-3-7-cagr-tmr
Emulsifiers Market for Personal Care Applications- https://www.globenewswire.com/news-release/2024/11/28/2988614/32656/en/Emulsifiers-Market-for-Personal-Care-Applications-to-Reach-3-0-Billion-by-2034-Fueled-by-Demand-for-Sustainable-and-Natural-Ingredients-TMR.html
AI-powered Chemical Manufacturing Market: https://www.globenewswire.com/news-release/2025/03/20/3046145/32656/en/AI-powered-Chemical-Manufacturing-Market-to-Expand-at-28-8-CAGR-Generating-US-37-6-Billion-by-2034-as-Industry-Embraces-Smart-Technologies-Latest-Report-by-Transparency-Market-Rese.html
Recombinant Chemicals Market : https://www.globenewswire.com/news-release/2025/01/31/3018829/32656/en/Recombinant-Chemicals-Market-to-Reach-US-6-7-Bn-by-2034-Driven-by-Rising-Demand-for-Protein-Based-Vaccines-Genetic-Disorder-Treatments-TMR-Analysis.html
About Transparency Market Research
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Contact Us:
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Insomnia Market Outlook 2031: From US$ 3.8 Billion in 2022 to US$ 6.4 Billion by 2031, Driven by Rising Prevalence and Innovative Therapies here
News-ID: 4077067 • Views: …
More Releases from Transparency Market Research

Transplant Diagnostics Market Outlook 2035: From US$ 7.8 Billion in 2024 to Over …
The global transplant diagnostics market, valued at US$ 7.8 billion in 2024, is projected to surpass US$ 17.2 billion by 2035, growing at a compound annual growth rate (CAGR) of 7.3% from 2025 to 2035. Transplant diagnostics involve tests and technologies, such as HLA typing, antibody detection, and molecular diagnostics, to ensure compatibility and monitor transplant success for organs like kidneys, livers, and hearts. This article explores the market dynamics,…

Malaysia Medical Tourism Market Outlook 2028: From US$ 1.2 Billion in 2020 to US …
The Malaysia medical tourism market, valued at US$ 1.2 billion in 2020, is projected to reach US$ 5.1 billion by 2028, expanding at a compound annual growth rate (CAGR) of 4.5% from 2021 to 2028. Malaysia is a leading destination for medical tourists, offering high-quality healthcare services, including cardiology, cosmetic surgery, and fertility treatments, at competitive prices. This article explores the market dynamics, challenges, and opportunities, and opportunities shaping the…

Wavefront Sensor Market Growth Accelerates on Back of Optical System Enhancement …
The Wavefront Sensor Market is experiencing robust growth, fueled by the rising demand for high-precision optical measurement technologies across diverse sectors, including ophthalmology, defense, astronomy, and laser diagnostics. Wavefront sensors play a critical role in detecting optical aberrations and enhancing image quality in real-time, making them essential components in adaptive optics systems and advanced imaging applications.
The global Wavefront Sensor Market was valued at USD 536.15 million in 2020 and is…

Spatial Transcriptomics Market Outlook 2034: USD 1.6 Billion by 2034, 14.3% CAGR …
The spatial transcriptomics market is experiencing a significant evolution, marked by rising interest in spatial biology and an increasing demand for high-resolution molecular profiling. Spatial transcriptomics, a cutting-edge technique that allows researchers to visualize and quantify gene activity in a tissue context, is revolutionizing genomics research by offering a deeper understanding of cellular behavior within tissue architecture. As the biotechnology and pharmaceutical sectors shift toward personalized medicine and targeted therapies,…
More Releases for Pharma
Antiemetics Market Size 2022 Analysis by Top Key Players| Acacia Pharma Group Pl …
Antiemetics Market research added by the Absolute Markets Insights, offers a comprehensive analysis of growth trends prevailing in the global business domain. This report also provides definitive data concerning market, size, commercialization aspects and revenue forecast of the industry. In addition, the study explicitly highlights the competitive status of key players within the projection timeline while focusing on their portfolio and regional expansion endeavors.
Access the PDF sample of the report@…
Global Indomethacin Market Seeking Excellent Growth by 2028 | Ratiopharm, Merck, …
"IBI has published a report entitled Global Indomethacin Market Research Report which provides comprehensive data on emerging trends, market drivers, growth opportunities, and barriers that could change the dynamics of the industry market. It provides an in-depth analysis of market segments which includes the product, application, and competitor analysis.
Click Here To Order A Sample Copy Of Indomethacin Global Market Report : https://www.infinitybusinessinsights.com/request_sample.php?id=380382
The Indomethacin Global Market Research Report provides close monitoring…
Roxatidine Market 2020: Top Companies Analysis To Grow Healthcare Business by 20 …
Business Industry Reports Research has recently announced a report on Global Roxatidine Market based on the Category Industry. The Roxatidine Market report emphasizes various key aspects, which include growth drivers, restraints, opportunities and recent market trends for the forecast period 2020-2024.
Global Roxatidine Market overview:
Business Industry Reports Analyst covers the Major Players data, including: shipment, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the…
Indometacin Market Top Key Manufacturers Aidarex, Ratiopharm, Merck, Xinhua Phar …
The Global Indometacin Market is a nonsteroidal anti-inflammatory drug commonly used as a prescription medication to reduce fever, pain, stiffness, and swelling from inflammation. The demand for nonsteroidal anti-inflammatory drug has been increasing owing to the emergence of anti-inflammatory biologics that are more targeted. However, such as side effects of anti-inflammatory drugs and patent expiry issues may hamper the market growth in the review period.
For More Info, Get Sample Report…
Hydroxycarbamide Market Study Report 2019| Taj Pharma, Beijing Jialin Pharma, Qi …
Los Angeles, United State, June 11, 2019, - The global Hydroxycarbamide market is expected to surge at a steady CAGR in the coming years, states the latest QY Research report. The publication offers an insightful take on the historical data of the market and the milestones it has achieved. The report also includes an assessment of current market trends and dynamics, which helps in mapping the trajectory of the global Hydroxycarbamide…
TIGLUTIK Market 2019: Top Players are Sanofi, Mylan Pharma, Apotex, Glemark Gene …
TIGLUTIK Market 2019 Report analyses the industry status, size, share, trends, growth opportunity, competition landscape and forecast to 2025. This report also provides data on patterns, improvements, target business sectors, limits and advancements. Furthermore, this research report categorizes the market by companies, region, type and end-use industry.
Get Sample Copy of this Report@ https://www.researchreportsworld.com/enquiry/request-sample/13709986
Global TIGLUTIK market 2019 research provides a basic overview of the industry including definitions, classifications, applications…